• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

B细胞非霍奇金恶性淋巴瘤中HLA-DR的表达:一项多参数流式细胞术研究

HLA-DR expression in B-cell non-Hodgkin's malignant lymphomas: a multiparameter flow cytometry study.

作者信息

Ratech H

机构信息

Fox Chase Cancer Center, Department of Pathology, Philadelphia, PA.

出版信息

Hum Pathol. 1990 Dec;21(12):1275-82. doi: 10.1016/s0046-8177(06)80042-0.

DOI:10.1016/s0046-8177(06)80042-0
PMID:2249840
Abstract

Ten cases of reactive follicular hyperplasia and 31 cases of B-cell non-Hodgkin's malignant lymphoma were studied using multiparameter flow cytometry. A bimodal distribution for HLA-DR expression, but not for surface immunoglobulin or B cell-specific antigens CD19 and CD20, was observed commonly in mixed cell type and infrequently in non-mixed cell type B-cell malignant lymphomas. On the basis of HLA-DR distribution alone, 31 cases of B-cell malignant lymphomas of low, intermediate, and high grades could be separated into mixed and non-mixed cell types, with only two misclassifications (P = 0.0001). Exceptionally, one case of malignant lymphoma, follicular and diffuse, mixed-cell type had a unimodal HLA-DR distribution, and one case of malignant lymphoma, diffuse, large noncleaved cell type had a bimodal HLA-DR distribution. In all cases of malignant lymphoma, follicular, mixed-cell type studied, low HLA-DR was correlated with small cells, and high HLA-DR was correlated with large cells. In contrast, HLA-DR expression and cell size were not as directly correlated in cases of malignant lymphoma, diffuse, mixed-cell type. These observations suggest that most, but not all, cases of B-cell malignant lymphomas of the mixed cell type can be separated from other B-cell lymphomas on the basis of HLA-DR distribution.

摘要

采用多参数流式细胞术对10例反应性滤泡增生和31例B细胞非霍奇金恶性淋巴瘤进行了研究。在混合细胞型B细胞恶性淋巴瘤中,常见HLA-DR表达呈双峰分布,而表面免疫球蛋白或B细胞特异性抗原CD19和CD20则不然,在非混合细胞型B细胞恶性淋巴瘤中则很少见。仅根据HLA-DR分布,31例低、中、高分级的B细胞恶性淋巴瘤可分为混合细胞型和非混合细胞型,仅有两例假分类(P = 0.0001)。例外的是,1例滤泡性和弥漫性混合细胞型恶性淋巴瘤的HLA-DR分布为单峰,1例弥漫性大无裂细胞型恶性淋巴瘤的HLA-DR分布为双峰。在所有研究的滤泡性混合细胞型恶性淋巴瘤病例中,低HLA-DR与小细胞相关,高HLA-DR与大细胞相关。相比之下,在弥漫性混合细胞型恶性淋巴瘤病例中,HLA-DR表达与细胞大小的相关性不那么直接。这些观察结果表明,大多数(但不是全部)混合细胞型B细胞恶性淋巴瘤病例可根据HLA-DR分布与其他B细胞淋巴瘤区分开来。

相似文献

1
HLA-DR expression in B-cell non-Hodgkin's malignant lymphomas: a multiparameter flow cytometry study.B细胞非霍奇金恶性淋巴瘤中HLA-DR的表达:一项多参数流式细胞术研究
Hum Pathol. 1990 Dec;21(12):1275-82. doi: 10.1016/s0046-8177(06)80042-0.
2
[Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases].112例淋巴系统恶性疾病的骨髓免疫表型分析
Ai Zheng. 2007 Apr;26(4):418-22.
3
Cytokine production (IL-1 alpha, IL-1 beta, and TNF alpha) and endothelial cell activation (ELAM-1 and HLA-DR) in reactive lymphadenitis, Hodgkin's disease, and in non-Hodgkin's lymphomas. An immunocytochemical study.反应性淋巴结炎、霍奇金病及非霍奇金淋巴瘤中细胞因子产生(白细胞介素-1α、白细胞介素-1β和肿瘤坏死因子α)及内皮细胞活化(E-选择素和人类白细胞抗原-DR):一项免疫细胞化学研究
Am J Pathol. 1990 Nov;137(5):1163-71.
4
HLA-DR antigen and bax protein expression in patients with primary non-Hodgkin's gastric lymphoma.原发性非霍奇金胃淋巴瘤患者的HLA-DR抗原及bax蛋白表达
Hybrid Hybridomics. 2004 Apr;23(2):87-92. doi: 10.1089/hyb.2004.23.87.
5
Immunophenotypic analysis of extranodal non-Hodgkin's lymphomas in the oral cavity.口腔结外非霍奇金淋巴瘤的免疫表型分析
Pathol Res Pract. 1993 Apr;189(3):300-11. doi: 10.1016/S0344-0338(11)80514-5.
6
The malignant lymphomas of Kenya: morphology, immunophenotype, and frequency of Epstein-Barr virus in 73 cases.肯尼亚的恶性淋巴瘤:73例病例的形态学、免疫表型及爱泼斯坦-巴尔病毒感染率
Hum Pathol. 1997 Sep;28(9):1026-33. doi: 10.1016/s0046-8177(97)90055-1.
7
Immunologic markers in non-Hodgkin's lymphoma.非霍奇金淋巴瘤中的免疫标志物
Hematol Oncol Clin North Am. 1991 Oct;5(5):871-89.
8
Molecular markers (PECAM-1, ICAM-3, HLA-DR) determine prognosis in primary non-Hodgkin's gastric lymphoma patients.分子标志物(PECAM-1、ICAM-3、HLA-DR)可确定原发性非霍奇金胃淋巴瘤患者的预后。
World J Gastroenterol. 2006 Mar 28;12(12):1924-32. doi: 10.3748/wjg.v12.i12.1924.
9
Clinicopathologic study of primary mediastinal non-lymphoblastic non-Hodgkin's lymphomas among the Japanese.日本原发性纵隔非淋巴细胞性非霍奇金淋巴瘤的临床病理研究
Acta Pathol Jpn. 1993 Jan-Feb;43(1-2):44-54. doi: 10.1111/j.1440-1827.1993.tb02913.x.
10
De novo CD5-positive and Richter's syndrome-associated diffuse large B cell lymphomas are genotypically distinct.原发性CD5阳性和里氏综合征相关的弥漫性大B细胞淋巴瘤在基因分型上是不同的。
Am J Pathol. 1995 Jul;147(1):207-16.

引用本文的文献

1
Fully human antibody exhibits pan-human leukocyte antigen-DR recognition and high in vitro/vivo efficacy against human leukocyte antigen-DR-positive lymphomas.全人源抗体表现出对人白细胞抗原-DR的广泛识别能力,并且在体外/体内对人白细胞抗原-DR阳性淋巴瘤具有高效性。
Cancer Sci. 2007 Jun;98(6):921-8. doi: 10.1111/j.1349-7006.2007.00469.x. Epub 2007 Apr 12.